SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Tonix announced publication of Phase 1 clinical data for TNX-1500 in the Journal of Clinical Immunology, showing the drug was well-tolerated with favo...
The closed-end investment company reported a GAAP net loss of $74.7 million ($3.63 per share) for Q4 ended March 31, 2026, driven by $77.6 million in ...
NorthWestern Energy Group disclosed forward-looking statements regarding its proposed merger with Black Hills Corporation at the Bank of America Power...
Dycom delivered record first quarter results with $1.965B in contract revenues, up 56.1%, and adjusted EPS of $4.42, exceeding guidance while announci...
Dick's Sporting Goods reported Q1 earnings of $3.54 per share with 6% comparable sales growth in its core business, while the Foot Locker acquisition ...
IMMUNIC, INC. has entered into an employment agreement with Erik Lundgren to serve as CEO effective May 22, 2026. The appointment represents a leaders...
Capri Holdings reported Q4 FY2026 results showing return to profitability with strategic initiatives for Michael Kors and Jimmy Choo gaining traction....
Apogee Therapeutics announced a strategic financing collaboration with Blackstone Life Sciences providing up to $1.3 billion in non-dilutive capital, ...
Apogee announced positive 16-week Part B induction dose optimization results from its Phase 2 APEX trial of zumilokibart, with 65.9% of mid-dose patie...
Nano Dimension agreed to sell its MarkForged subsidiary to Stratasys for $42.5 million in an all-cash transaction expected to close in H2 2026. The sa...
Streamex Corp. announced the appointment of Kori Handy as Vice President of Product and Design, bringing 18 years of fintech and SaaS experience from ...
Lumen Technologies filed amended and restated articles of incorporation detailing authorized capital structure of 2.2 billion common shares and 2 mill...
Artificial Intelligence Technology Solutions' RAD subsidiary converted a 30-day retail security pilot into a long-term recurring revenue agreement for...
# FDA Approves ANDA for Somerset Therapeutics Somerset Therapeutics LLC has received FDA approval for an abbreviated new drug application (ANDA219529...
Camber Pharmaceuticals Inc. won final FDA approval Tuesday for its generic 25-mg losartan potassium and hydrochlorothiazide tablets, completing a proc...
Data Storage Corporation entered into an equity distribution agreement with Maxim Group LLC to sell authorized but unissued common stock as a sales ag...
BCPC I, LLC requested and received a new $50 million commitment under its credit agreement with Goldman Sachs Bank USA, effective May 21, 2026. The in...
Rani Therapeutics Holdings filed warrant documentation allowing holders to purchase Class A Common Stock at a specified exercise price starting from t...
News Corporation filed an ASX notification for a buyback program authorizing repurchases of up to $1 billion in Class A common stock. The program repr...
Michael Gillespie & Associates, PLLC has confirmed agreement with Goldenwell Biotech's statements regarding auditor changes filed on May 26, 2026. Thi...